PSMA-positive prostatic volume prediction with deep learning based on T2-weighted MRI.

Artificial intelligence Neural network PET/MRI Prediction Prostate cancer

Journal

La Radiologia medica
ISSN: 1826-6983
Titre abrégé: Radiol Med
Pays: Italy
ID NLM: 0177625

Informations de publication

Date de publication:
03 May 2024
Historique:
received: 31 07 2023
accepted: 16 04 2024
medline: 3 5 2024
pubmed: 3 5 2024
entrez: 3 5 2024
Statut: aheadofprint

Résumé

High PSMA expression might be correlated with structural characteristics such as growth patterns on histopathology, not recognized by the human eye on MRI images. Deep structural image analysis might be able to detect such differences and therefore predict if a lesion would be PSMA positive. Therefore, we aimed to train a neural network based on PSMA PET/MRI scans to predict increased prostatic PSMA uptake based on the axial T2-weighted sequence alone. All patients undergoing simultaneous PSMA PET/MRI for PCa staging or biopsy guidance between April 2016 and December 2020 at our institution were selected. To increase the specificity of our model, the prostatic beds on PSMA PET scans were dichotomized in positive and negative regions using an SUV threshold greater than 4 to generate a PSMA PET map. Then, a C-ENet was trained on the T2 images of the training cohort to generate a predictive prostatic PSMA PET map. One hundred and fifty-four PSMA PET/MRI scans were available (133 [ Increased prostatic PSMA uptake on PET might be estimated based on T2 MRI alone. Further investigation with larger cohorts and external validation is needed to assess whether PSMA uptake can be predicted accurately enough to help in the interpretation of mpMRI.

Identifiants

pubmed: 38700556
doi: 10.1007/s11547-024-01820-z
pii: 10.1007/s11547-024-01820-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s).

Références

Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, Collaco-Moraes Y, Ward K, Hindley RG, Freeman A, Kirkham AP, Oldroyd R, Parker C, Emberton M, PROMIS Study Group (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389:815–822. https://doi.org/10.1016/S0140-6736(16)32401-1
doi: 10.1016/S0140-6736(16)32401-1 pubmed: 28110982
Freifeld Y, Xi Y, Passoni N, Woldu S, Hornberger B, Goldberg K, Bagrodia A, Raj G, Margulis V, Cadeddu JA, Lotan Y, Francis F, Pedrosa I, Roehrborn C, Costa DN (2019) Optimal sampling scheme in men with abnormal multiparametric MRI undergoing MRI-TRUS fusion prostate biopsy. Urol Oncol 37:57–62. https://doi.org/10.1016/j.urolonc.2018.10.009
doi: 10.1016/j.urolonc.2018.10.009 pubmed: 30446460
Barkovich EJ, Shankar PR, Westphalen AC (2019) A systematic review of the existing prostate imaging reporting and data system version 2 (PI-RADSv2) literature and subset meta-analysis of PI-RADSv2 categories stratified by gleason scores. AJR Am J Roentgenol 212:847–854. https://doi.org/10.2214/AJR.18.20571
doi: 10.2214/AJR.18.20571 pubmed: 30807218
Ferraro DA, Laudicella R, Zeimpekis K, Mebert I, Müller J, Maurer A, Grünig H, Donati O, Sapienza MT, Rueschoff JH, Rupp N, Eberli D, Burger IA (2022) Hot needles can confirm accurate lesion sampling intraoperatively using [
doi: 10.1007/s00259-021-05599-3 pubmed: 34725726
Mingels C, Bohn KP, Rominger A, Afshar-Oromieh A, Alberts I (2022) Diagnostic accuracy of [
doi: 10.1007/s00259-022-05693-0 pubmed: 35067735 pmcid: 9165245
Laudicella R, Skawran S, Ferraro DA, Mühlematter UJ, Maurer A, Grünig H, Rüschoff HJ, Rupp N, Donati O, Eberli D, Burger IA (2022) Quantitative imaging parameters to predict the local staging of prostate cancer in intermediate- to high-risk patients. Insights Imaging 13:75. https://doi.org/10.1186/s13244-022-01217-4
doi: 10.1186/s13244-022-01217-4 pubmed: 35426518 pmcid: 9012878
Eiber M, Weirich G, Holzapfel K, Souvatzoglou M, Haller B, Rauscher I, Beer AJ, Wester HJ, Gschwend J, Schwaiger M, Maurer T (2016) Simultaneous
doi: 10.1016/j.eururo.2015.12.053 pubmed: 26795686
Park SY, Zacharias C, Harrison C, Fan RE, Kunder C, Hatami N, Giesel F, Ghanouni P, Daniel B, Loening AM, Sonn GA, Iagaru A (2018) Gallium 68 PSMA-11 PET/MR imaging in patients with intermediate- or high-risk prostate cancer. Radiology 288:495–505. https://doi.org/10.1148/radiol.2018172232
doi: 10.1148/radiol.2018172232 pubmed: 29786490
blinded for revision
Ferraro DA, Hötker AM, Becker AS, Mebert I, Laudicella R, Baltensperger A, Rupp NJ, Rueschoff JH, Müller J, Mortezavi A, Sapienza MT, Eberli D, Donati OF, Burger IA (2022)
doi: 10.1186/s41824-022-00135-4 pubmed: 35843966 pmcid: 9288941
Rüschoff JH, Ferraro DA, Muehlematter UJ, Laudicella R, Hermanns T, Rodewald AK, Moch H, Eberli D, Burger IA, Rupp NJ (2021) What’s behind
doi: 10.1007/s00259-021-05501-1 pubmed: 34386839 pmcid: 8484204
Papp L, Spielvogel CP, Grubmüller B, Grahovac M, Krajnc D, Ecsedi B, Sareshgi RAM, Mohamad D, Hamboeck M, Rausch I, Mitterhauser M, Wadsak W, Haug AR, Kenner L, Mazal P, Susani M, Hartenbach S, Baltzer P, Helbich TH, Kramer G, Shariat SF, Beyer T, Hartenbach M, Hacker M (2021) Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [
doi: 10.1007/s00259-020-05140-y pubmed: 33341915
Moazemi S, Erle A, Khurshid Z, Lütje S, Muders M, Essler M, Schultz T, Bundschuh RA (2021) Decision-support for treatment with
doi: 10.21037/atm-20-6446 pubmed: 34268431 pmcid: 8246232
Alongi P, Laudicella R, Stefano A, Caobelli F, Comelli A, Vento A, Sardina D, Ganduscio G, Toia P, Ceci F, Mapelli P, Picchio M, Midiri M, Baldari S, Lagalla R, Russo G (2022) Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics study. Q J Nucl Med Mol Imaging 66:352–360. https://doi.org/10.23736/S1824-4785.20.03227-6
doi: 10.23736/S1824-4785.20.03227-6 pubmed: 32543166
Woythal N, Arsenic R, Kempkensteffen C, Miller K, Janssen JC, Huang K, Makowski MR, Brenner W, Prasad V (2018) Immunohistochemical validation of PSMA expression measured by
doi: 10.2967/jnumed.117.195172 pubmed: 28775203
Fendler WP, Eiber M, Beheshti M, Bomanji J, Ceci F, Cho S, Giesel F, Haberkorn U, Hope TA, Kopka K, Krause BJ, Mottaghy FM, Schöder H, Sunderland J, Wan S, Wester HJ, Fanti S, Herrmann K (2017)
doi: 10.1007/s00259-017-3670-z pubmed: 28283702
Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin JC, Pujol S, Bauer C, Jennings D, Fennessy F, Sonka M, Buatti J, Aylward S, Miller JV, Pieper S, Kikinis R (2012) 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging 30:1323–1341. https://doi.org/10.1016/j.mri.2012.05.001
doi: 10.1016/j.mri.2012.05.001 pubmed: 22770690 pmcid: 3466397
Nioche C, Orlhac F, Boughdad S, Reuzé S, Goya-Outi J, Robert C, Pellot-Barakat C, Soussan M, Frouin F, Buvat I (2018) LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res 78:4786–4789. https://doi.org/10.1158/0008-5472.CAN-18-0125
doi: 10.1158/0008-5472.CAN-18-0125 pubmed: 29959149
Stefano A, Comelli A (2021) Customized efficient neural network for COVID-19 infected region identification in CT images. J Imaging 7:131. https://doi.org/10.3390/jimaging7080131
doi: 10.3390/jimaging7080131 pubmed: 34460767 pmcid: 8404925
Paszke A, Chaurasia A, Kim S, Culurciello E (2016) ENet: a deep neural network architecture for real-time semantic segmentation. arXiv:1606.02147
Cuocolo R, Comelli A, Stefano A, Benfante V, Dahiya N, Stanzione A, Castaldo A, De Lucia DR, Yezzi A, Imbriaco M (2021) Deep learning whole-gland and zonal prostate segmentation on a public MRI dataset. J Magn Reson Imaging 54:452–459. https://doi.org/10.1002/jmri.27585
doi: 10.1002/jmri.27585 pubmed: 33634932
Salvaggio G, Comelli A, Portoghese M, Cutaia G, Cannella R, Vernuccio F, Stefano A, Dispensa N, La Tona G, Salvaggio L, Calamia M, Gagliardo C, Lagalla R, Midiri M (2022) Deep learning network for segmentation of the prostate gland with median lobe enlargement in T2-weighted MR images: comparison with manual segmentation method. Curr Probl Diagn Radiol 51:328–333. https://doi.org/10.1067/j.cpradiol.2021.06.006
doi: 10.1067/j.cpradiol.2021.06.006 pubmed: 34315623
Kingma, DP, Ba J (2015) A method for stochastic optimization. In: Proceedings of the 3rd international conference on learning representations, ICLR 2015—conference track proceedings 2015. arXiv:1412.6980
Comelli A, Dahiya N, Stefano A, Benfante V, Gentile G, Agnese V, Raffa GM, Pilato M, Yezzi A, Petrucci G, Pasta S (2020) Deep learning approach for the segmentation of aneurysmal ascending aorta. Biomed Eng Lett 11:15–24. https://doi.org/10.1007/s13534-020-00179-0
doi: 10.1007/s13534-020-00179-0 pubmed: 33747600 pmcid: 7930147
Ronneberger O, Fischer P, Brox T (2015) U-net: convolutional networks for biomedical image segmentation. In: Proceedings of the lecture notes in computer science (including subseries lecture notes in artificial intelligence and lecture notes in bioinformatics), Fuzhou, China, 13–15 November 2015
Gallivanone F, Stefano A, Grosso E, Canevari C, Gianolli L, Messa C, Gilardi MC, Castiglioni I (2011) PVE correction in PET-CT whole-body oncological studies from PVE-affected images. IEEE Trans Nucl Sci 58:736–747. https://doi.org/10.1109/TNS.2011.2108316
doi: 10.1109/TNS.2011.2108316
Chandrashekar A, Handa A, Ward J, Grau V, Lee R (2022) A deep learning pipeline to simulate fluorodeoxyglucose (FDG) uptake in head and neck cancers using non-contrast CT images without the administration of radioactive tracer. Insights Imaging 13:45. https://doi.org/10.1186/s13244-022-01161-3
doi: 10.1186/s13244-022-01161-3 pubmed: 35286501 pmcid: 8921434
Komori S, Cross DJ, Mills M, Ouchi Y, Nishizawa S, Okada H, Norikane T, Thientunyakit T, Anzai Y, Minoshima S (2022) Deep-learning prediction of amyloid deposition from early-phase amyloid positron emission tomography imaging. Ann Nucl Med 36:913–921. https://doi.org/10.1007/s12149-022-01775-z
doi: 10.1007/s12149-022-01775-z pubmed: 35913591
Ji H, Lafata K, Mowery Y, Brizel D, Bertozzi AL, Yin FF, Wang C (2022) Post-radiotherapy PET image outcome prediction by deep learning under biological model guidance: a feasibility study of oropharyngeal cancer application. Front Oncol 12:895544. https://doi.org/10.3389/fonc.2022.895544
doi: 10.3389/fonc.2022.895544 pubmed: 35646643 pmcid: 9135979
Laudicella R, Rüschoff JH, Ferraro DA, Brada MD, Hausmann D, Mebert I, Maurer A, Hermanns T, Eberli D, Rupp NJ, Burger IA (2022) Infiltrative growth pattern of prostate cancer is associated with lower uptake on PSMA PET and reduced diffusion restriction on mpMRI. Eur J Nucl Med Mol Imaging 49:3917–3928. https://doi.org/10.1007/s00259-022-05787-9
doi: 10.1007/s00259-022-05787-9 pubmed: 35435496 pmcid: 9399036

Auteurs

Riccardo Laudicella (R)

Department of Nuclear Medicine, University Hospital Zürich, University of Zurich, Zurich, Switzerland. riclaudi@hotmail.it.
Nuclear Medicine Unit, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, Messina, Italy. riclaudi@hotmail.it.
Ri.MED Foundation, Palermo, Italy. riclaudi@hotmail.it.

Albert Comelli (A)

Ri.MED Foundation, Palermo, Italy.

Moritz Schwyzer (M)

Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.

Alessandro Stefano (A)

Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Cefalù, Italy.

Ender Konukoglu (E)

Computer Vision Lab, ETH Zurich, Zurich, Switzerland.

Michael Messerli (M)

Department of Nuclear Medicine, University Hospital Zürich, University of Zurich, Zurich, Switzerland.

Sergio Baldari (S)

Nuclear Medicine Unit, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, Messina, Italy.

Daniel Eberli (D)

Department of Urology, University Hospital of Zürich, Zurich, Switzerland.

Irene A Burger (IA)

Department of Nuclear Medicine, University Hospital Zürich, University of Zurich, Zurich, Switzerland.
Department of Nuclear Medicine, Cantonal Hospital Baden, Baden, Switzerland.

Classifications MeSH